Advertisement

Vaccinology and the Goal of Health for All

  • V. Ramalingaswami
Conference paper
Part of the Progress in Vaccinology book series (VACCINOLOGY, volume 2)

Abstract

Edward Jenner, who can truly be described as the first immunologist, coined the term vaccine from the Latin vaccinus, meaning “of the Cows” in 1798, almost two centuries ago (13). In 1796 Jenner inoculated an 8-year-old boy with material from a cowpox lesion for prevention of smallpox. The last case of naturally occurring smallpox was reported from Somalia in October 1977. Thus it took 181 years to rid the world of smallpox after the discovery of an effective vaccine. Smallpox is now a finished story.

Keywords

Typhoid Fever Pertussis Vaccine Neisseria Meningitidis Oral Vaccine Acellular Pertussis Vaccine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Blumberg BS: Overview: hepatitis B virus and primary hepatocellular carcinoma, in Hepatitis Viruses and Hepatocellular Carcinoma. Tokyo, Academic Press, 1985, pp 3–13.Google Scholar
  2. 2.
    Clemens JD, Harris JR, Khan MR, et al: Field trial of oral cholera vaccines in Bangladesh. Lancet 1986; 2: 124–127.PubMedCrossRefGoogle Scholar
  3. 3.
    Edelman R, Levine MM: Summary of an international workshop on typhoid fever. Rev Infect Dis 1986; 8: 329–349.PubMedCrossRefGoogle Scholar
  4. 4.
    Editorial: Oral cholera vaccines. Lancet 1986; 2: 722–723.Google Scholar
  5. 5.
    Einhorn MS, Anderson EL, Winberg GA, et al: Immunogenicity in infants of Haemophilus influenzae type B polysaccharide in a conjugate vaccine with Neisseria meningitidis outer membrane protein. Lancet 1986; 2: 299–302.PubMedCrossRefGoogle Scholar
  6. 6.
    Fields BH: What biotechnology has to offer vaccine development in International Symposium on Vaccine Development and Utilization. Washington, DC, Agency for International Development, 1986.Google Scholar
  7. 7.
    Fine PEM, Ponnighaus JM, Maine N, et al: Protection efficiency of BCG against leprosy in Northern Malawi. Lancet 1986; 2: 499–54.PubMedCrossRefGoogle Scholar
  8. 8.
    Galazka, A: Immunization of Pregnant Women. EPI/GEN/83/5. Geneva, WHO, 1985.Google Scholar
  9. 9.
    Guerrant RL: Amoebiasis: introduction, current status and research questions. Rev Infect Dis 1986; 8: 218–227.PubMedCrossRefGoogle Scholar
  10. 10.
    Hopkins, DR . Beyond smallpox eradication: assignment children. 1985,69/ 72: 235–242.Google Scholar
  11. 11.
    Jordan WS Jr. Impediments to the development of additional vaccines, vaccines against important diseases will not be available in the next decade in International Symposium on Vaccine Development and Utilization. Washington, DC, Agency for International Development, 1986.Google Scholar
  12. 12.
    Keusch GT, Scrimshaw NS: Selective primary health care strategies for control of disease in the developing world. XXIII. Control of infection to reduce the prev¬alence of infantile and childhood malnutrition. Rev Infect Dis 1986; 8: 273–287.PubMedCrossRefGoogle Scholar
  13. 13.
    Population Reports: Issues in World Health, Immunizing the World’s Children. Series 1, No. 5, March-April 1986.Google Scholar
  14. 14.
    Report of the U.S. Public Health Service Interagency Group to Monitor Vaccine development, production and usage: Pertussis and Pertussis Vaccines in Japan. Washington, DC, U.S. Department of Health and Human Services, 1986.Google Scholar
  15. 15.
    Rogers L: The rapid cure of amoebic dysentery and hepatitis by hypodermic injection of soluble salts of emetine. Br Med J 1912; 1: 1424–1425.PubMedCrossRefGoogle Scholar
  16. 16.
    Riley ID, Lehman D, Alpers MP, et al: Pneumococcal vaccine prevents death from acute Lower respiratory tract infections in Papua New Guinea children. Lancet 1986; 2: 877–880.PubMedCrossRefGoogle Scholar
  17. 17.
    Shofield F: Selective primary care: strategies for control of disease in the developing world. XXII. Tetanus—a preventable problem. Rev. Infect Dis. 1986; 8: 144–156.CrossRefGoogle Scholar
  18. 18.
    Tuberculosis Prevention Trial, Madras. Trial of BCG vaccines in South India for tuberculosis prevention. Ind. J. Med. Res. 1980; 72 (Suppl): 1–74.Google Scholar
  19. 19.
    Tripathy SP: The case for BCG. Ann. Nat Acad Med Sei India 1983; 19: 11–21.Google Scholar

Copyright information

© Springer-Verlag New York Inc. 1989

Authors and Affiliations

  • V. Ramalingaswami

There are no affiliations available

Personalised recommendations